BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 29078883)

  • 1. Doxorubicin effect is enhanced by sphingosine-1-phosphate signaling antagonist in breast cancer.
    Katsuta E; Yan L; Nagahashi M; Raza A; Sturgill JL; Lyon DE; Rashid OM; Hait NC; Takabe K
    J Surg Res; 2017 Nov; 219():202-213. PubMed ID: 29078883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interstitial Fluid Sphingosine-1-Phosphate in Murine Mammary Gland and Cancer and Human Breast Tissue and Cancer Determined by Novel Methods.
    Nagahashi M; Yamada A; Miyazaki H; Allegood JC; Tsuchida J; Aoyagi T; Huang WC; Terracina KP; Adams BJ; Rashid OM; Milstien S; Wakai T; Spiegel S; Takabe K
    J Mammary Gland Biol Neoplasia; 2016 Jun; 21(1-2):9-17. PubMed ID: 27194029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting the SphK1/S1P/S1PR1 Axis That Links Obesity, Chronic Inflammation, and Breast Cancer Metastasis.
    Nagahashi M; Yamada A; Katsuta E; Aoyagi T; Huang WC; Terracina KP; Hait NC; Allegood JC; Tsuchida J; Yuza K; Nakajima M; Abe M; Sakimura K; Milstien S; Wakai T; Spiegel S; Takabe K
    Cancer Res; 2018 Apr; 78(7):1713-1725. PubMed ID: 29351902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Sphingosine 1-Phosphate Analogue FTY720 Alleviates Seizure-induced Overexpression of P-Glycoprotein in Rat Hippocampus.
    Gao F; Gao Y; Meng F; Yang C; Fu J; Li Y
    Basic Clin Pharmacol Toxicol; 2018 Jul; 123(1):14-20. PubMed ID: 29380527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma Sphingosine-1-Phosphate Levels Are Associated with Progression of Estrogen Receptor-Positive Breast Cancer.
    Ikarashi M; Tsuchida J; Nagahashi M; Takeuchi S; Moro K; Toshikawa C; Abe S; Ichikawa H; Shimada Y; Sakata J; Koyama Y; Sato N; Hait NC; Ling Y; Okuda S; Takabe K; Wakai T
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FTY720 (Fingolimod) attenuates basal and sphingosine-1-phosphate-evoked thyroid cancer cell invasion.
    Kalhori V; Magnusson M; Asghar MY; Pulli I; Törnquist K
    Endocr Relat Cancer; 2016 May; 23(5):457-68. PubMed ID: 26935838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sphingosine-1-phosphate produced by sphingosine kinase 1 promotes breast cancer progression by stimulating angiogenesis and lymphangiogenesis.
    Nagahashi M; Ramachandran S; Kim EY; Allegood JC; Rashid OM; Yamada A; Zhao R; Milstien S; Zhou H; Spiegel S; Takabe K
    Cancer Res; 2012 Feb; 72(3):726-35. PubMed ID: 22298596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sphingosine-1-Phosphate Prevents Egress of Hematopoietic Stem Cells From Liver to Reduce Fibrosis.
    King A; Houlihan DD; Kavanagh D; Haldar D; Luu N; Owen A; Suresh S; Than NN; Reynolds G; Penny J; Sumption H; Ramachandran P; Henderson NC; Kalia N; Frampton J; Adams DH; Newsome PN
    Gastroenterology; 2017 Jul; 153(1):233-248.e16. PubMed ID: 28363640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of phosphorylation of immunomodulatory agent FTY720 (fingolimod) on antiproliferative activity against breast and colon cancer cells.
    Nagaoka Y; Otsuki K; Fujita T; Uesato S
    Biol Pharm Bull; 2008 Jun; 31(6):1177-81. PubMed ID: 18520051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FTY720 (Fingolimod) Inhibits HIF1 and HIF2 Signaling, Promotes Vascular Remodeling, and Chemosensitizes in Renal Cell Carcinoma Animal Model.
    Gstalder C; Ader I; Cuvillier O
    Mol Cancer Ther; 2016 Oct; 15(10):2465-2474. PubMed ID: 27507852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevation of serum sphingosine-1-phosphate attenuates impaired cardiac function in experimental sepsis.
    Coldewey SM; Benetti E; Collino M; Pfeilschifter J; Sponholz C; Bauer M; Huwiler A; Thiemermann C
    Sci Rep; 2016 Jun; 6():27594. PubMed ID: 27277195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sphk1/S1P/S1PR1 Signaling is Involved in the Development of Autoimmune Thyroiditis in Patients and NOD.H-2
    Han C; He X; Xia X; Guo J; Liu A; Liu X; Wang X; Li C; Peng S; Zhao W; Zhou M; Shi X; Li Y; Li Y; Shan Z; Teng W
    Thyroid; 2019 May; 29(5):700-713. PubMed ID: 30963819
    [No Abstract]   [Full Text] [Related]  

  • 13. Sphingosine-1-phosphate signaling: A novel target for simultaneous adjuvant treatment of triple negative breast cancer and chemotherapy-induced neuropathic pain.
    Singh SK; Spiegel S
    Adv Biol Regul; 2020 Jan; 75():100670. PubMed ID: 31708456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased plasma sphingosine-1-phosphate in obese individuals and its capacity to increase the expression of plasminogen activator inhibitor-1 in adipocytes.
    Ito S; Iwaki S; Koike K; Yuda Y; Nagasaki A; Ohkawa R; Yatomi Y; Furumoto T; Tsutsui H; Sobel BE; Fujii S
    Coron Artery Dis; 2013 Dec; 24(8):642-50. PubMed ID: 24212262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FTY720 and cisplatin synergistically induce the death of cisplatin-resistant melanoma cells through the downregulation of the PI3K pathway and the decrease in epidermal growth factor receptor expression.
    Ishitsuka A; Fujine E; Mizutani Y; Tawada C; Kanoh H; Banno Y; Seishima M
    Int J Mol Med; 2014 Oct; 34(4):1169-74. PubMed ID: 25109763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of a sphingosine 1-phosphate receptor antagonist prodrug.
    Kennedy PC; Zhu R; Huang T; Tomsig JL; Mathews TP; David M; Peyruchaud O; Macdonald TL; Lynch KR
    J Pharmacol Exp Ther; 2011 Sep; 338(3):879-89. PubMed ID: 21632869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of basal-like breast cancer growth by FTY720 in combination with epidermal growth factor receptor kinase blockade.
    Martin JL; Julovi SM; Lin MZ; de Silva HC; Boyle FM; Baxter RC
    Breast Cancer Res; 2017 Aug; 19(1):90. PubMed ID: 28778177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sphingosine 1-phosphate enhances the excitability of rat sensory neurons through activation of sphingosine 1-phosphate receptors 1 and/or 3.
    Li C; Li JN; Kays J; Guerrero M; Nicol GD
    J Neuroinflammation; 2015 Apr; 12():70. PubMed ID: 25880547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant expression of the S1P regulating enzymes, SPHK1 and SGPL1, contributes to a migratory phenotype in OSCC mediated through S1PR2.
    Patmanathan SN; Johnson SP; Lai SL; Panja Bernam S; Lopes V; Wei W; Ibrahim MH; Torta F; Narayanaswamy P; Wenk MR; Herr DR; Murray PG; Yap LF; Paterson IC
    Sci Rep; 2016 May; 6():25650. PubMed ID: 27160553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sphingosine-1-phosphate signalling-a key player in the pathogenesis of Angiotensin II-induced hypertension.
    Meissner A; Miro F; Jiménez-Altayó F; Jurado A; Vila E; Planas AM
    Cardiovasc Res; 2017 Feb; 113(2):123-133. PubMed ID: 28082452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.